Metir says pathogen detector phase 2 progressing toward commercialisation in early 2027
The company also said it is developing a new antibody mass production method to meet market demand from Q1 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.